Work

Farnesyltransferase inhibitor tipifarnib is well tolerated, induces stabilization of disease, and inhibits farnesylation and oncogenic/tumor survival pathways in patients with advanced multiple myeloma

FWCI: 18.56
Cites: 34
Cited by: 187
Related to: 8